Drugs / α- thioctic acid
last change Dec 2021 re-read 2 minutes ago

α- thioctic acid

Developed for
type 2 diabetes mellitus

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00948324 Comparator Jun 2008 → May 2019 type 2 diabetes mellitus Sun Yat-sen University Suspended No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as α- thioctic acid “ALA:CSII combined with two weeks α- thioctic acid (600mg/500ml NaCl, 0.9%), ivdrip QD.” NCT00948324
Route Intravenous “α- thioctic acid (600mg/500ml NaCl, 0.9%), ivdrip QD.” NCT00948324